Oncology is a branch of science that investigates cancer cells. The oncology devices market includes medical devices that aid in the diagnosis and treatment of cancer diseases. Early screening and detection are critical for successful cancer treatment. Cancer can strike anyone at any point in life.
Main Highlights of the Report
Increasing Number of Patients
The number of patients affected by different types of cancer such as lung cancer, colorectal cancer and breast cancer is It is increasing day by day for various reasons. According to a report released by WHO in 2018, lung cancer is the predominant cancer, with about 1.69 million deaths in 2015. This ever-growing patient population is projected to boost the growth of the oncology medical devices market.
Rising consumption of tobacco products
In developing countries such as Brazil, China and India, more and more people are consuming tobacco, which is the main cause of lung cancer in the patient population. is the cause. Increasing consumption of tobacco products is expected to drive the growth of the oncology medical devices market.
Helping in Diagnosis and Treatment
Oncology medical devices have proven to be very helpful in diagnosing and treating cancer, and are expected to boost the growth of the oncology medical devices market. Expected.
Key Players in the Oncology Medical Devices Market
The report comprises company profiling of various key players in the market. Includes company profiles, company finances, mergers and acquisitions, recent developments, and risk analysis for each company. Industry leaders in the oncology medical devices market include Accuray Technologies, GE Healthcare, Eckert and Ziegler BEBIG, IBA Group, Biogenex Laboratories, Varian Medical Systems, C.R Bard Inc., Roche Diagnostics, and Elekta AB.
Oncology Medical Devices Market Segmentation
); by treatment (chemotherapy, hormone therapy, biotherapy and radiotherapy); by diagnosis (biopsy, imaging, endoscopy, blood test), etc. Historical and current statistics of the market are used to analyze each segment and its sub-segments. The market share and growth of each segment are further evaluated.
North America is expected to hold a large share in the market during the forecast period due to the rising incidence of cancer in the region. About 1.73 million new cancer cases were diagnosed in the United States in 2017, according to the National Cancer Institute. Additionally, in 2017, approximately 15,270 children and adolescents under the age of 19 were diagnosed with cancer.
[About the details of the research report in Japanese]
https://www.researchnester.jp/reports/global-oncology-medical-devices-market/1700
< br>Europe is expected to grow at a significant rate on the back of a growing cancer population and the availability of favorable reimbursement policies for cancer diagnosis.
The oncology medical devices market is further segmented based on region.
Report Sample URL: https://www.researchnester.jp/sample-request-1700
Company Overview of Research Nester Private Limited
Research, a group company of LAMORI PRIVATE LIMITED Nester Private Limited is a leading strategic market research and consulting services provider. We aim to provide unbiased and unrivaled market insight and industry analysis to assist the industry. We also help the industry make smart decisions about future marketing strategies, expansions and investments.
https://www.researchnester.com/
[Details of the research report]
https://www.researchnester.com/reports/global- oncology-medical-devices-market/1700
Phone: US+1 646 586 9123
Phone: UK +44 203 608 5919
Email: info@researchnester.com
>
*The following is special information for media personnel only. Please refrain from disclosing information on personal SNS etc.
This press release contains information for members of the media.
After registering as a media user, you can view various special information such as contact information for company representatives and information on events and press conferences.
*The content varies depending on the press release.